{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:07:11Z","timestamp":1779448031062,"version":"3.53.1"},"reference-count":25,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Frailty is a validated predictor of waitlist mortality and perioperative risk in liver transplant candidates, but its association with early post-transplant outcomes in large real-world cohorts remains incompletely characterized. This study evaluated the association between administratively defined pre-transplant frailty and early clinical outcomes following liver transplantation. Methods: We conducted a retrospective cohort study using the TriNetX US Collaborative Research Network. Adults undergoing first-time isolated liver transplantation through February 2026 were included. Frailty was identified using ICD-10-CM codes for frailty, sarcopenia, cachexia, weakness, abnormal gait\/mobility, or reduced mobility documented within 12 months before transplantation; patients coded only for nonspecific weakness were excluded from the frailty cohort. Patients underwent 1:1 propensity score matching using 18 baseline covariates, including demographics, comorbidities, laboratory values, albumin, and MELD-Na. The primary outcome was all-cause mortality at 7, 30, and 90 days. Secondary outcomes included acute kidney injury, prolonged mechanical ventilation, vasopressor requirement\/hemodynamic instability, renal replacement therapy, ICU and hospital length of stay, and 90-day readmission. Sensitivity analyses used a restrictive \u2265 2-code frailty definition and substituted MELD 3.0 for MELD-Na in the propensity model. Results: Among 4860 eligible recipients, 742 had administratively defined frailty and 4118 did not. After matching, 730 patients remained in each group with well-balanced covariates. Administratively defined frailty was associated with higher mortality at 7, 30, and 90 days, with numerically smaller relative risks at later time points. It was also associated with higher risks of acute kidney injury, prolonged mechanical ventilation, vasopressor requirement\/hemodynamic instability, renal replacement therapy, longer ICU and hospital stays, and 90-day readmission. Findings were directionally consistent in both sensitivity analyses. Etiology-stratified analyses were exploratory and showed no statistically significant heterogeneity across liver disease etiologies. Conclusions: In this large propensity-matched multicenter cohort, administratively defined pre-transplant frailty was associated with worse early outcomes after liver transplantation. Because frailty and several outcomes were identified using structured EHR and administrative data, findings should be interpreted as associative and hypothesis-generating. Prospective studies using validated frailty instruments and granular donor, intraoperative, and center-level variables are needed to confirm these findings.<\/jats:p>","DOI":"10.3390\/jcm15114003","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:07:47Z","timestamp":1779444467000},"page":"4003","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Pre-Transplant Frailty on Early Outcomes Following Liver Transplantation: A Propensity-Matched Multicenter Cohort Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-2884","authenticated-orcid":false,"given":"Noor","family":"Albusta","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Lahey Hospital and Medical Center, Burlington, MA 01805, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdulla","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Isa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Royal College of Surgeons in Ireland, Medical University of Bahrain, Adliya P.O. Box 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain","family":"Alrahma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Salmaniya Medical Complex, Manama P.O. Box 12, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1053\/j.gastro.2019.01.028","article-title":"Frailty associated with waitlist mortality independent of ascites and hepatic encephalopathy in a multicenter study","volume":"156","author":"Lai","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.31406","article-title":"Identifying an optimal Liver Frailty Index cutoff to predict waitlist mortality in liver transplant candidates","volume":"73","author":"Kardashian","year":"2021","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/HEP.0000000000001644","article-title":"AASLD\/AST practice guideline on adult liver transplantation: Candidate evaluation","volume":"83","author":"Dove","year":"2026","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/hep.32268","article-title":"Frailty, mortality, and health care utilization after liver transplantation: From the multicenter Functional Assessment in Liver Transplantation (FrAILT) study","volume":"75","author":"Lai","year":"2022","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/HEP.0000000000001320","article-title":"The Liver Transplant Comorbidity Index (LTCI): A composite index of ambulatory pre-LT factors to identify patients at increased risk of post-LT mortality","volume":"83","author":"Lai","year":"2025","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/HEP.0000000000001030","article-title":"Liver transplantation provides survival benefit at all levels of frailty: From the multicenter Functional Assessment in Liver Transplantation study","volume":"81","author":"Wang","year":"2025","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.14309\/ajg.0000000000001376","article-title":"Prehabilitation-driven changes in frailty metrics predict mortality in patients with advanced liver disease","volume":"116","author":"Lin","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ajt.2026.01.007","article-title":"Feasibility, safety, and effectiveness of prehabilitation programs in patients awaiting liver transplantation: A systematic review and meta-analysis","volume":"26","author":"Martel","year":"2026","journal-title":"Am. J. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ludwig, R.J., Anson, M., Zirpel, H., Thaci, D., Olbrich, H., Bieber, K., Kridin, K., Dempfle, A., Curman, P., and Zhao, S.S. (2025). A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1516126"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e70198","DOI":"10.1002\/pds.70198","article-title":"TriNetX Dataworks-USA: Overview of a multi-purpose, de-identified, federated electronic health record real-world data and analytics network and comparison to the US census","volume":"34","author":"Stein","year":"2025","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_12","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012). KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl., 2, 1\u2013138."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MEG.0000000000003119","article-title":"Impact of sarcopenia on outcomes in liver transplant recipients: A nationwide analysis","volume":"38","author":"Lin","year":"2025","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/JS9.0000000000001861","article-title":"Association between frailty and acute kidney injury after cardiac surgery: Unraveling the moderation effect of body fat through an international, retrospective, multicohort study","volume":"111","author":"Bai","year":"2025","journal-title":"Int. J. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"116571","DOI":"10.1016\/j.amjsurg.2025.116571","article-title":"Frailty impacts outcomes for all older adult age groups in emergency laparotomy","volume":"249","author":"Arda","year":"2025","journal-title":"Am. J. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jhep.2018.02.004","article-title":"Recipient characteristics and morbidity and mortality after liver transplantation","volume":"69","author":"Asrani","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1097\/TP.0000000000002810","article-title":"Prediction of perioperative mortality of cadaveric liver transplant recipients during their evaluations","volume":"103","author":"Molinari","year":"2019","journal-title":"Transplantation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.30828","article-title":"A North American expert opinion statement on sarcopenia in liver transplantation","volume":"70","author":"Carey","year":"2019","journal-title":"Hepatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/lt.25591","article-title":"Sarcopenia in chronic liver disease: Impact on outcomes","volume":"25","author":"Ooi","year":"2019","journal-title":"Liver Transpl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S2468-1253(22)00268-0","article-title":"Enhanced recovery for liver transplantation: Recommendations from the 2022 International Liver Transplantation Society consensus conference","volume":"8","author":"Pollok","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.surg.2021.07.001","article-title":"Enhanced recovery in liver transplantation: A value-based approach to complex surgical care","volume":"170","author":"Feizpour","year":"2021","journal-title":"Surgery"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/wjs.12600","article-title":"Efficacy of perioperative application of enhanced recovery after surgery on elderly recipients underwent liver transplantation","volume":"49","author":"He","year":"2025","journal-title":"World J. Surg."},{"key":"ref_23","first-page":"179","article-title":"Advances in the postoperative care of the liver transplant recipient","volume":"32","author":"Campbell","year":"2026","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_24","first-page":"e202","article-title":"Home-based LIver FrailTy Intervention (LIFT) in transplant candidates: A feasibility study","volume":"109","author":"Thuluvath","year":"2025","journal-title":"Transplantation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/11\/4003\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:36:14Z","timestamp":1779446174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/11\/4003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15114003"],"URL":"https:\/\/doi.org\/10.3390\/jcm15114003","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}